The role of chemokines and chemokine receptors in CNS inflammation
- 1 January 2001
- book chapter
- Published by Elsevier
- Vol. 132, 533-544
- https://doi.org/10.1016/s0079-6123(01)32101-5
Abstract
No abstract availableThis publication has 50 references indexed in Scilit:
- Expression of the β-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissueJournal of Neuroimmunology, 2000
- Chemokine receptor antagonism as a new therapy for multiple sclerosisExpert Opinion on Investigational Drugs, 2000
- Chemokines and chemokine receptors in the pathogenesis of multiple sclerosisMultiple Sclerosis Journal, 2000
- CCR5 Δ32, matrix metalloproteinase-9 and disease activity in multiple sclerosisJournal of Neuroimmunology, 2000
- Prevention of Experimental Autoimmune Encephalomyelitis by MIP-1α and MCP-1 Naked DNA VaccinesJournal of Autoimmunity, 1999
- Enhanced expression of MCP-1, rantes and MIP-1α,β in demyelinating multiple sclerosis lesions and human adult astrocyte culturesJournal of Neuroimmunology, 1998
- Expression of monocyte chemoattractant protein-1 and other β-chemokines by resident glia and inflammatory cells in multiple sclerosis lesionsJournal of Neuroimmunology, 1998
- Cytokines in inflammatory brain lesions: helpful and harmfulTrends in Neurosciences, 1996
- Chemokine expression in murine experimental allergic encephalomyelitisJournal of Neuroimmunology, 1995
- Cytokine mRNA expression in inflammatory multiple sclerosis lesions: Detection by non-radioactive in situ hybridizationCytokine, 1993